Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02323581 · ClinicalTrials.gov registry record · NA
Endovascular Treatment of TAAA and Aortic Arch Aneurysms Using Fenestrated and Branched Stent Grafts
A NA study of Aortic Aneurysm, Thoracic and Aortic Aneurysm, Thoracoabdominal, sponsored by Darren Schneider, M.D..
- Recruiting
- Registry status
- NA
- Development phase
- 520
- Enrollment target
- 2
- Study locations
NCT02323581: Recruiting NA study of Aortic Aneurysm, Thoracic and Aortic Aneurysm, Thoracoabdominal, sponsored by Darren Schneider, M.D..
NCT02323581 is a NA study of Aortic Aneurysm, Thoracic and Aortic Aneurysm, Thoracoabdominal that is actively recruiting participants, run by Darren Schneider, M.D.. The registered enrollment target is 520 participants, above the 116-participant average among 4 other Aortic Aneurysm, Thoracic trials with a reported enrollment target (348% higher). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02323581, a NA study of Aortic Aneurysm, Thoracic and Aortic Aneurysm, Thoracoabdominal, is actively recruiting participants, sponsored by Darren Schneider, M.D..
- RECRUITING
- Registry status
- NA
- Development phase
- 520 participants
- Enrollment target
- 2
- Study locations
Study Summary
Prospective, nonrandomized, single-center, two-arm study to assess the feasibility and safety and to evaluate clinical outcomes of endovascular repair of complex aortic aneurysms (thoracoabdominal aortic aneurysms and aortic arch aneurysms) in patients at high risk for open surgery.
Primary Outcome
Successful deployment of the TAAA device or Physician-Specified TAAA Devices, or Aortic Arch device \& bridging covered stents into all targeted mesenteric \& renal, or supra-aortic arteries with stent-graft \& all branches patent by intraop angiography
Conditions Studied
Interventions
- DEVICE Endovascular treatment of Thoracoabdominal Aortic Aneurysm
- DEVICE Endovascular treatment of Aortic Arch Aneurysms
Study Locations (2)
New York
- New York Presbyterian Hospital - New York
Pennsylvania
- Hospital of the University of Pennsylvania - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 520 participants |
| Start Date | 2013-11 |
| Est. Completion | 2033-12 |
| Phase | NA |
What NCT02323581 shows while recruiting
NCT02323581 is an interventional study that assigns participants to a tested intervention. The registered 520 participants enrollment target is mid-sized for trials with a published cap, above the 116-participant average among 4 other Aortic Aneurysm, Thoracic trials with a reported enrollment target (348% higher).
The record links to 3 conditions, with Aortic Aneurysm, Thoracic appearing as the primary indexed condition, and to 2 interventions - of which Endovascular treatment of Thoracoabdominal Aortic Aneurysm is the first listed.
NCT02323581 reports a single indexed study location in New York, Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT02323581 about?
NCT02323581 is a clinical study titled "Endovascular Treatment of TAAA and Aortic Arch Aneurysms Using Fenestrated and Branched Stent Grafts". Prospective, nonrandomized, single-center, two-arm study to assess the feasibility and safety and to evaluate clinical outcomes of endovascular repair of complex aortic aneurysms (thoracoabdominal aortic aneurysms and aortic arch aneurysms) in patients at high risk for open surgery.
What is the current status of trial NCT02323581?
This trial is currently recruiting. It is a NA study. The enrollment target is 520 participants. The study started on 2013-11. Estimated completion is 2033-12.
What conditions does trial NCT02323581 study?
This clinical trial studies the following conditions: Aortic Aneurysm, Thoracic, Aortic Aneurysm, Thoracoabdominal, Aortic Dissection, Thoracoabdominal.
What interventions are being tested in trial NCT02323581?
The interventions under investigation include: Endovascular treatment of Thoracoabdominal Aortic Aneurysm (DEVICE), Endovascular treatment of Aortic Arch Aneurysms (DEVICE).
Who is sponsoring clinical trial NCT02323581?
This trial is sponsored by Darren Schneider, M.D., which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02323581 being conducted?
This trial has 2 study locations across New York, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Aortic Aneurysm, Thoracic
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Evaluation of the GORE® TBE Device in the Treatment of Lesions of the Aortic Arch and Descending Thoracic Aorta, Zone 2
ACTIVE NOT RECRUITING · NA
-
Evaluation of the GORE® TBE Device in the Treatment of Lesions of the Aortic Arch and Descending Thoracic Aorta, Zone 0/1
ACTIVE NOT RECRUITING · NA
-
RelayPro Thoracic Stent-Graft in Subjects With Thoracic Aortic Aneurysms and Penetrating Atherosclerotic Ulcers
ACTIVE NOT RECRUITING · NA
-
GORE TAG® Thoracic Endoprosthesis - 45 mm for the Treatment of Aneurysms of the Descending Thoracic Aorta
COMPLETED · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04656496 · 520 participants · NA
NOURISH-T+: Promoting Healthy Eating and Exercise Behaviors
- NCT05445778 · 520 participants · Phase 3
Mirvetuximab Soravtansine With Bevacizumab Versus Bevacizumab as Maintenance in Platinum-sensitive Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer
- NCT05498428 · 520 participants · Phase 2
A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer
- NCT05908240 · 520 participants · NA
Prevention of Cardiovascular Disease and Mortality in Patients With Psoriasis or Psoriatic Arthritis
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia